Shanghai Science and Technology Innovation Group's "Large Enterprise Strategy Source" platform ChenYao Capital sets sail, gradually establishing a series of funds around three models

On July 4th, at the first Medical Device and Pharmaceutical Innovation Source Conference, the first fund brand "Chenyiao Capital" under Shanghai Guotou Company, which carries the "Large Enterprise Source" function, officially launched. Qin Liang, General Manager of Shanghai Technology Venture Capital Co., Ltd., stated in an interview with Securities Times that Chenyiao Capital, as a fund platform, will gradually establish a series of funds around three models. Among them, in terms of large enterprise mergers and acquisitions, the first merger fund "Chenyiao Xincheng" has been completed, with a target total scale of 1.1 billion yuan, and the first acquisition transaction has been completed; in terms of large enterprise output, it will jointly establish funds with leading enterprises to spin off the products and pipelines being researched by large enterprises, forming independent project companies to jointly empower the development of project companies, which may either go public after growing stronger or be repurchased by large enterprises; in terms of large enterprise incubation, it will focus on the current pipelines and technology needs of large enterprises, proactively laying out a number of small enterprises, emphasizing the synergy of new technologies and new products with large enterprises